This content is from: Patents

In-house pharma lawyers share outside counsel criteria

Lawyers from Sanofi, BMS, Regeneron, and Roivant discuss their relationships with outside counsel, and emphasise the importance of diversity

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial